These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1531796

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serotonin and platelet activation during treatment with isradipine.
    Fetkovska N, Sebekova K, Fedelesova V, Dzurik R.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S31-3. PubMed ID: 1720482
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Does calcium channel blockade and beta-adrenergic blockade affect platelet function and fibrinolysis to a varying degree?
    Gleerup G, Mehlsen J, Winther K.
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):87-9. PubMed ID: 7723358
    [Abstract] [Full Text] [Related]

  • 10. First clinical experience with isradipine in the treatment of hypertension in Portugal.
    Rocha-Gonçalves F, Mariano-Pego G, Viegas J, Correia JM, Botelho MA.
    J Cardiovasc Pharmacol; 1991 Jan; 18 Suppl 3():S4-6. PubMed ID: 1720485
    [Abstract] [Full Text] [Related]

  • 11. Effects of dihydropyridines and their combination with aspirin on blood pressure and circadian platelet activity in patients with essential hypertension.
    Tison P, Ulicna L, Jakubovska Z, Oravcova J, Fetkovska N.
    Am J Hypertens; 1994 Jul; 7(7 Pt 2):46S-49S. PubMed ID: 7946179
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antihypertensive and hemodynamic effects of calcium channel blockade with isradipine after acute exercise.
    Cléroux J, Yardley C, Marshall A, Coulombe D, Lacourcière Y.
    Am J Hypertens; 1992 Feb; 5(2):84-7. PubMed ID: 1532316
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of isradipine on in-vivo platelet function.
    O'Grady J, Kritz H, Schmid P, Pirich C, Sinzinger H.
    Thromb Res; 1997 Jun 01; 86(5):363-71. PubMed ID: 9211627
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of isradipine sustained release on platelet function and fibrinolysis in essential hypertensives with or without other risk factors.
    Ranieri G, Filitti V, Andriani A, Bonfantino MV, Lamontanara G, Cavallo A, Milani M, De Cesaris R.
    Cardiovasc Drugs Ther; 1996 May 01; 10(2):119-23. PubMed ID: 8842503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.